Eton Pharmaceuticals, Inc. (ETON) Insider Trading

Name: Eton Pharmaceuticals, Inc. (ETON) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 6, 2026): David Krempa (Chief Business Officer): Exercise/Conversion of 10,522 shares.

Get alerted when insiders trade ETON

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta